# Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life

> **NCT07719088** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Charles Raison** · enrollment: 50 (estimated)

## Conditions studied

- Aging
- Longevity
- Biomarkers of Aging

## Interventions

- **DRUG:** Psilocybin (Usona Institute)

## Key facts

- **NCT ID:** NCT07719088
- **Lead sponsor:** Charles Raison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2028-04
- **Final completion:** 2028-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719088, "Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07719088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*